180 related articles for article (PubMed ID: 31465295)
1. Characterization of the duration of treatment with diazoxide in infants with prolonged hyperinsulinism (PHI).
Raisingani M; Brar PC
J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1241-1245. PubMed ID: 31465295
[TBL] [Abstract][Full Text] [Related]
2. Complications of diazoxide treatment in persistent neonatal hyperinsulinism.
Abu-Osba YK; Manasra KB; Mathew PM
Arch Dis Child; 1989 Oct; 64(10):1496-500. PubMed ID: 2684032
[TBL] [Abstract][Full Text] [Related]
3. Higher C-peptide levels and glucose requirements may identify neonates with transient hyperinsulinism hypoglycemia who will benefit from diazoxide treatment.
Davidov AS; Elkon-Tamir E; Haham A; Shefer G; Weintrob N; Oren A; Lebenthal Y; Mandel D; Eyal O
Eur J Pediatr; 2020 Apr; 179(4):597-602. PubMed ID: 31863303
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and insulin regulation in infants with a syndrome of prolonged neonatal hyperinsulinism.
Hoe FM; Thornton PS; Wanner LA; Steinkrauss L; Simmons RA; Stanley CA
J Pediatr; 2006 Feb; 148(2):207-12. PubMed ID: 16492430
[TBL] [Abstract][Full Text] [Related]
5. Hyperinsulinism in infants and children: diagnosis and therapy.
Stanley CA; Baker L
Adv Pediatr; 1976; 23():315-55. PubMed ID: 795282
[No Abstract] [Full Text] [Related]
6. Neonatal hyperinsulinism secondary to maternal intake of high-sugar drinks.
West NJ; Thorpe M
BMJ Case Rep; 2011 Jul; 2011():. PubMed ID: 22689550
[TBL] [Abstract][Full Text] [Related]
7. Palliative treatment of hyperinsulinism with cyproheptadine and diazoxide.
Rotenstein D; Serbin S; Welsh T
Pediatrics; 1992 Aug; 90(2 Pt 1):212-5. PubMed ID: 1379358
[TBL] [Abstract][Full Text] [Related]
8. Challenges in management of transient hyperinsulinism - a retrospective analysis of 36 severely affected children.
Hoermann H; Roeper M; Salimi Dafsari R; Koestner F; Reinauer C; Mayatepek E; Meissner T; Kummer S
J Pediatr Endocrinol Metab; 2021 Jul; 34(7):867-875. PubMed ID: 33860651
[TBL] [Abstract][Full Text] [Related]
9. Liver injury may increase the risk of diazoxide toxicity: a case report.
Tas E; Mahmood B; Garibaldi L; Sperling M
Eur J Pediatr; 2015 Mar; 174(3):403-6. PubMed ID: 25618267
[TBL] [Abstract][Full Text] [Related]
10. Low-dose diazoxide is safe and effective in infants with transient hyperinsulinism.
Malhotra N; Yau D; Cunjamalay A; Gunasekara B; S A; Gilbert C; Morgan K; Dattani M; Dastamani A
Clin Endocrinol (Oxf); 2024 Feb; 100(2):132-137. PubMed ID: 38059644
[TBL] [Abstract][Full Text] [Related]
11. Ten years' experience of persistent hyperinsulinaemic hypoglycaemia of infancy.
Tyrrell VJ; Ambler GR; Yeow WH; Cowell CT; Silink M
J Paediatr Child Health; 2001 Oct; 37(5):483-8. PubMed ID: 11885714
[TBL] [Abstract][Full Text] [Related]
12. Transient hyperinsulinism in an asphyxiated newborn infant with hypoglycemia.
Clark W; O'Donovan D
Am J Perinatol; 2001 Jun; 18(4):175-8. PubMed ID: 11444360
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of persistent hyperinsulinaemic hypoglycaemia. A series of 175 cases.
de Lonlay P; Fournet JC; Touati G; Groos MS; Martin D; Sevin C; Delagne V; Mayaud C; Chigot V; Sempoux C; Brusset MC; Laborde K; Bellane-Chantelot C; Vassault A; Rahier J; Junien C; Brunelle F; Nihoul-Fékété C; Saudubray JM; Robert JJ
Eur J Pediatr; 2002 Jan; 161(1):37-48. PubMed ID: 11808879
[TBL] [Abstract][Full Text] [Related]
14. Metabolic effects of diazoxide in normal subjects, patients with diabetes mellitus, and patients with organic hypoglycemia.
Steinke J; Soeldner JS
Ann N Y Acad Sci; 1968 Apr; 150(2):326-36. PubMed ID: 4299223
[No Abstract] [Full Text] [Related]
15. Factors associated with neonatal hyperinsulinemic hypoglycemia, a case-control study.
Rattanasakol T; Kitsommart R
J Pediatr Endocrinol Metab; 2024 Mar; 37(3):243-249. PubMed ID: 38235510
[TBL] [Abstract][Full Text] [Related]
16. The treatment effect of diazoxide on 44 patients with congenital hyperinsulinism.
Hu S; Xu Z; Yan J; Liu M; Sun B; Li W; Sang Y
J Pediatr Endocrinol Metab; 2012; 25(11-12):1119-22. PubMed ID: 23329758
[TBL] [Abstract][Full Text] [Related]
17. The evolving course of HNF4A hyperinsulinaemic hypoglycaemia--a case series.
McGlacken-Byrne SM; Hawkes CP; Flanagan SE; Ellard S; McDonnell CM; Murphy NP
Diabet Med; 2014 Jan; 31(1):e1-5. PubMed ID: 23796040
[TBL] [Abstract][Full Text] [Related]
18. Case Report: Neurodevelopmental Outcome in a Small-for-Gestational-Age Infant With Symptomatic Hyperinsulinemic Hypoglycemia, Gaze Preference, and Infantile Spasms.
Chandran S; Teoh KW; Janardhan K; Yap F
Front Endocrinol (Lausanne); 2022; 13():818252. PubMed ID: 35721755
[TBL] [Abstract][Full Text] [Related]
19. Diazoxide for Severe or Recurrent Neonatal Hypoglycemia: A Randomized Clinical Trial.
Laing D; Walsh EPG; Alsweiler JM; Hanning SM; Meyer MP; Ardern J; Cutfield WS; Rogers J; Gamble GD; Chase JG; Harding JE; McKinlay CJD
JAMA Netw Open; 2024 Jun; 7(6):e2415764. PubMed ID: 38869900
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic glucagon levels in infants and children with hyperinsulinemia.
Pronicka E; Gruszczyńska B; Woźniewicz B; Cedro A; Kamiński W; Leśniewska A
J Pediatr; 1995 Jun; 126(6):948-51. PubMed ID: 7776103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
